Read more: To view or add a comment, sign in New CardioBites episode Recent advances in drug therapy for hypertrophic cardiomyopathy (HCM) are transforming patient outcomesimproving symptoms, quality of life, and long-term management
Coverage of GLP-1s for weight loss has become particularly controversial: a 2025 ICER report noted only 18% of large employers cover these drugs ( [26] ), and 3052% of obesity-drug prescriptions were denied by payers as not covered ( [27] )
This appears to be the major cause of semaglutide hair loss
The peptide may help in more ways than one when it comes to sex
Before you leave, calculate the time difference between your departure and destination points
Whether you are running a planned peptide cycle or storing reconstituted vials for ongoing research, the protocols here will protect your investment and keep your compounds potent from the first dose to the last